Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Increased by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 13.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 36,863 shares of the medical equipment provider’s stock after purchasing an additional 4,356 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Intuitive Surgical were worth $12,436,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. OFI Invest Asset Management bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $25,000. Baystate Wealth Management LLC raised its holdings in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC boosted its stake in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares in the last quarter. Headinvest LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth $28,000. Finally, Stone House Investment Management LLC lifted its holdings in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, VP Marshall Mohr sold 108,790 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the sale, the vice president now owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the transaction, the vice president now owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 1,605 shares of Intuitive Surgical stock in a transaction on Friday, March 1st. The stock was sold at an average price of $383.48, for a total transaction of $615,485.40. Following the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $114,277.04. The disclosure for this sale can be found here. Insiders sold 147,416 shares of company stock valued at $56,867,167 in the last ninety days. Insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ISRG shares. Citigroup raised their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Jefferies Financial Group lifted their price target on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Raymond James upped their price objective on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Get Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Trading Down 1.2 %

Intuitive Surgical stock traded down $4.74 on Monday, reaching $381.96. 542,118 shares of the stock were exchanged, compared to its average volume of 1,574,812. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $403.76. The firm has a fifty day moving average price of $384.98 and a two-hundred day moving average price of $353.72. The stock has a market cap of $135.48 billion, a PE ratio of 69.73, a PEG ratio of 5.00 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the company earned $1.00 earnings per share. The firm’s revenue was up 11.5% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.